Parallel Import allows medicinal products authorised in other EU member states to be marketed in Sweden provided the imported products have no therapeutic difference from the equivalent nationally authorized products.
The granting of licences in the EU for such a purpose began in 1994. The Medical Products Agency liaises closely with the relevant competent authorities to obtain the necessary information to ensure that only those products which fully comply with the stringent criteria for parallel import are granted a licence.